EcoDrugPlus

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSSTOG00000006041
Gene Symbol: APH1A
4 Cross references
137 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSSTOG00000016049
Gene Symbol: APH1B
4 Cross references
191 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSSTOG00000010096
Gene Symbol: APEX1
4 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSSTOG00000006319
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSSTOG00000015946
Gene Symbol: ALOX5
3 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSSTOG00000010915
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSTOG00000026613
Gene Symbol: AVPR1A
3 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSSTOG00000027172
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSTOG00000008352
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSSTOG00000003086
Gene Symbol: AHR
4 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSSTOG00000011958
Gene Symbol: AURKA
2 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSSTOG00000005405
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).